Praluent
- Product NDC
- 72733-5901
- 11-digit product format
- 727335901
- Labeler code
- 72733
- Product ID
- 72733-5901_9f6bfdfc-2991-4bd3-85c8-0f0c446f6d1d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- alirocumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Sanofi US Corporation
- Application
- BLA125559
- Marketing category
- BLA
- Marketing start
- 2019-02-15
- Marketing end
- 0000-00-00
- Substance
- ALIROCUMAB
- Active strength
- 75 mg/mL
- Pharmacologic classes
- PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72733-5901-2 | 72733590102 | 2 SYRINGE, GLASS in 1 CARTON (72733-5901-2) > 1 mL in 1 SYRINGE, GLASS | 2019-02-15 | 0000-00-00 | No | No | Current |